Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza.

Morita M, Kuba K, Ichikawa A, Nakayama M, Katahira J, Iwamoto R, Watanebe T, Sakabe S, Daidoji T, Nakamura S, Kadowaki A, Ohto T, Nakanishi H, Taguchi R, Nakaya T, Murakami M, Yoneda Y, Arai H, Kawaoka Y, Penninger JM, Arita M, Imai Y.

Cell. 2013 Mar 28;153(1):112-25. doi: 10.1016/j.cell.2013.02.027.

2.

Lessons from lipids in the fight against influenza.

GarcĂ­a-Sastre A.

Cell. 2013 Jul 3;154(1):22-3. doi: 10.1016/j.cell.2013.06.024.

3.

Low-dose interferon Type I treatment is effective against H5N1 and swine-origin H1N1 influenza A viruses in vitro and in vivo.

Haasbach E, Droebner K, Vogel AB, Planz O.

J Interferon Cytokine Res. 2011 Jun;31(6):515-25. doi: 10.1089/jir.2010.0071.

PMID:
21323570
4.

Proinflammatory cytokine response and viral replication in mouse bone marrow derived macrophages infected with influenza H1N1 and H5N1 viruses.

Chan RW, Leung CY, Nicholls JM, Peiris JS, Chan MC.

PLoS One. 2012;7(11):e51057. doi: 10.1371/journal.pone.0051057.

5.

Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.

Haasbach E, Pauli EK, Spranger R, Mitzner D, Schubert U, Kircheis R, Planz O.

Antiviral Res. 2011 Sep;91(3):304-13. doi: 10.1016/j.antiviral.2011.07.006.

PMID:
21777621
6.

Inhibition of influenza A virus replication by antagonism of a PI3K-AKT-mTOR pathway member identified by gene-trap insertional mutagenesis.

Murray JL, McDonald NJ, Sheng J, Shaw MW, Hodge TW, Rubin DH, O'Brien WA, Smee DF.

Antivir Chem Chemother. 2012 May 14;22(5):205-15. doi: 10.3851/IMP2080.

PMID:
22374988
7.

PA from an H5N1 highly pathogenic avian influenza virus activates viral transcription and replication and induces apoptosis and interferon expression at an early stage of infection.

Wang Q, Zhang S, Jiang H, Wang J, Weng L, Mao Y, Sekiguchi S, Yasui F, Kohara M, Buchy P, Deubel V, Xu K, Sun B, Toyoda T.

Virol J. 2012 Jun 8;9:106. doi: 10.1186/1743-422X-9-106.

8.

Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity.

Mazur I, Wurzer WJ, Ehrhardt C, Pleschka S, Puthavathana P, Silberzahn T, Wolff T, Planz O, Ludwig S.

Cell Microbiol. 2007 Jul;9(7):1683-94.

PMID:
17324159
9.

PB2 protein of a highly pathogenic avian influenza virus strain A/chicken/Yamaguchi/7/2004 (H5N1) determines its replication potential in pigs.

Manzoor R, Sakoda Y, Nomura N, Tsuda Y, Ozaki H, Okamatsu M, Kida H.

J Virol. 2009 Feb;83(4):1572-8. doi: 10.1128/JVI.01879-08.

10.

Virulence and genetic compatibility of polymerase reassortant viruses derived from the pandemic (H1N1) 2009 influenza virus and circulating influenza A viruses.

Song MS, Pascua PN, Lee JH, Baek YH, Park KJ, Kwon HI, Park SJ, Kim CJ, Kim H, Webby RJ, Webster RG, Choi YK.

J Virol. 2011 Jul;85(13):6275-86. doi: 10.1128/JVI.02125-10.

11.

Antisense oligonucleotides targeting the RNA binding region of the NP gene inhibit replication of highly pathogenic avian influenza virus H5N1.

Zhang T, Wang TC, Zhao PS, Liang M, Gao YW, Yang ST, Qin C, Wang CY, Xia XZ.

Int Immunopharmacol. 2011 Dec;11(12):2057-61. doi: 10.1016/j.intimp.2011.08.019.

PMID:
21933722
12.

Viral replication and innate host responses in primary human alveolar epithelial cells and alveolar macrophages infected with influenza H5N1 and H1N1 viruses.

Yu WC, Chan RW, Wang J, Travanty EA, Nicholls JM, Peiris JS, Mason RJ, Chan MC.

J Virol. 2011 Jul;85(14):6844-55. doi: 10.1128/JVI.02200-10.

13.

In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.

Sleeman K, Mishin VP, Deyde VM, Furuta Y, Klimov AI, Gubareva LV.

Antimicrob Agents Chemother. 2010 Jun;54(6):2517-24. doi: 10.1128/AAC.01739-09.

14.

Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge.

Perrone LA, Ahmad A, Veguilla V, Lu X, Smith G, Katz JM, Pushko P, Tumpey TM.

J Virol. 2009 Jun;83(11):5726-34. doi: 10.1128/JVI.00207-09.

15.

Small interfering RNA targeting m2 gene induces effective and long term inhibition of influenza A virus replication.

Sui HY, Zhao GY, Huang JD, Jin DY, Yuen KY, Zheng BJ.

PLoS One. 2009 May 22;4(5):e5671. doi: 10.1371/journal.pone.0005671.

16.

Receptor tyrosine kinase inhibitors that block replication of influenza a and other viruses.

Kumar N, Sharma NR, Ly H, Parslow TG, Liang Y.

Antimicrob Agents Chemother. 2011 Dec;55(12):5553-9. doi: 10.1128/AAC.00725-11.

17.

Role of omega-3 PUFA-derived mediators, the protectins, in influenza virus infection.

Imai Y.

Biochim Biophys Acta. 2015 Apr;1851(4):496-502. doi: 10.1016/j.bbalip.2015.01.006. Review.

PMID:
25617737
18.

The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a gammadelta T cell population in humanized mice.

Tu W, Zheng J, Liu Y, Sia SF, Liu M, Qin G, Ng IH, Xiang Z, Lam KT, Peiris JS, Lau YL.

J Exp Med. 2011 Jul 4;208(7):1511-22. doi: 10.1084/jem.20110226.

19.

Early control of H5N1 influenza virus replication by the type I interferon response in mice.

Szretter KJ, Gangappa S, Belser JA, Zeng H, Chen H, Matsuoka Y, Sambhara S, Swayne DE, Tumpey TM, Katz JM.

J Virol. 2009 Jun;83(11):5825-34. doi: 10.1128/JVI.02144-08.

20.

Effect of oral gavage treatment with ZnAL42 and other metallo-ion formulations on influenza A H5N1 and H1N1 virus infections in mice.

Barnard DL, Wong MH, Bailey K, Day CW, Sidwell RW, Hickok SS, Hall TJ.

Antivir Chem Chemother. 2007;18(3):125-32.

PMID:
17626596
Items per page

Supplemental Content

Support Center